These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30008433)

  • 1. Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation.
    Mangal S; Park H; Zeng L; Yu HH; Lin YW; Velkov T; Denman JA; Zemlyanov D; Li J; Zhou QT
    Int J Pharm; 2018 Sep; 548(1):443-453. PubMed ID: 30008433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections.
    Mangal S; Huang J; Shetty N; Park H; Lin YW; Yu HH; Zemlyanov D; Velkov T; Li J; Zhou QT
    Int J Pharm; 2019 Apr; 561():102-113. PubMed ID: 30797863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.
    Yu S; Wang S; Zou P; Chai G; Lin YW; Velkov T; Li J; Pan W; Zhou QT
    Int J Pharm; 2020 Feb; 575():118915. PubMed ID: 31816354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.
    Zhou QT; Gengenbach T; Denman JA; Yu HH; Li J; Chan HK
    AAPS J; 2014 Jan; 16(1):37-47. PubMed ID: 24129586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and Rifampicin.
    Wang W; Zhou QT; Sun SP; Denman JA; Gengenbach TR; Barraud N; Rice SA; Li J; Yang M; Chan HK
    AAPS J; 2016 Mar; 18(2):372-84. PubMed ID: 26603890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation.
    Mangal S; Xu R; Park H; Zemlyanov D; Shetty N; Lin YW; Morton D; Chan HK; Li J; Zhou QT
    Pharm Res; 2018 Nov; 36(1):6. PubMed ID: 30406281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.
    Pathak V; Park H; Zemlyanov D; Bhujbal SV; Ahmed MU; Azad MAK; Li J; Zhou QT
    Pharm Res; 2022 Nov; 39(11):2781-2799. PubMed ID: 35915320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface Composition and Aerosolization Stability of an Inhalable Combinational Powder Formulation Spray Dried Using a Three-Fluid Nozzle.
    Shetty N; Zhang Y; Park H; Zemlyanov D; Shah D; He A; Ahn P; Mutukuri TT; Chan HK; Zhou QT
    Pharm Res; 2020 Oct; 37(11):219. PubMed ID: 33037471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
    Zhou QT; Sun SP; Chan JG; Wang P; Barraud N; Rice SA; Wang J; Li J; Chan HK
    Mol Pharm; 2015 Aug; 12(8):2594-603. PubMed ID: 25423590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation.
    Mangal S; Nie H; Xu R; Guo R; Cavallaro A; Zemlyanov D; Zhou QT
    Pharm Res; 2018 Jan; 35(2):28. PubMed ID: 29374368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combined colistin and meropenem against meropenem resistant
    Gunalan A; Sarumathi D; Sastry AS; Ramanathan V; Rajaa S; Sistla S
    Indian J Pharmacol; 2021; 53(3):207-212. PubMed ID: 34169905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
    Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
    Wang J; Kutter JP; Mu H; Moodley A; Yang M
    Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii.
    Marie MA; Krishnappa LG; Alzahrani AJ; Mubaraki MA; Alyousef AA
    Bosn J Basic Med Sci; 2015 Oct; 15(4):24-9. PubMed ID: 26614848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Pankuch GA; Lin G; Seifert H; Appelbaum PC
    Antimicrob Agents Chemother; 2008 Jan; 52(1):333-6. PubMed ID: 17967915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
    Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC
    Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder?
    Zhou QT; Loh ZH; Yu J; Sun SP; Gengenbach T; Denman JA; Li J; Chan HK
    AAPS J; 2016 Sep; 18(5):1213-1224. PubMed ID: 27255350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.
    Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G
    Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.